Clinical progression of progressive supranuclear palsy: impact of trials bias and phenotype variants

Abstract excerpt

Abstract Progressive supranuclear palsy causes diverse clinical presentations, including classical Richardson’s syndrome and several variant phenotypes. Clinical trials of disease-modifying therapies have recently been completed, with more planned for the next 2 years. However, many people with progressive supranuclear palsy do not meet eligibility criteria for these clinical trials. Understanding clinical...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Ginkgo biloba and Cashew Applications
• Share to Nuclear Receptors and Signaling
• Share to Parkinson's Disease Mechanisms and Treatments